We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT01801527
Previous Study | Return to List | Next Study

Telehealth System to Improve Quality of Life in Breast Cancer Survivors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01801527
Recruitment Status : Completed
First Posted : February 28, 2013
Last Update Posted : October 27, 2017
Carlos III Health Institute
Information provided by (Responsible Party):
Manuel Arroyo Morales, Universidad de Granada

Brief Summary:

Background: Cancer is increasingly viewed as a chronic disease and therefore there is a growing need for long-term treatments. Breast cancer survivors suffer physical impairment after oncology treatment. This impairment reduces quality of life (QoL) and increases the prevalence of conditions associated to unhealthy life-style.

Objective: The overall objective of e-Cuidate telerehabilitation will be to evaluate short and long-term effects telehealth program.

Methods: Seventy-two breast cancer survivors (age range: 18-65 years) will be recruited through oncology and breast units at the Virgen de las Nieves Hospital and San Cecilio Hospital and associations of breast cancer patients in Granada. Patients will be randomized to receive the online rehabilitation group (n=36) or usual care (control) group (n=36). Telerehabilitation group will receive an eight-week online intervention and control group receive recommendations about usual care.

Discussion: The investigators study attempts to increase the level of fitness and reduce musculoskeletal disorders in breast cancer patients through a strategy for care based on telerehabilitation to promote therapeutic exercise.

Condition or disease Intervention/treatment Phase
Breast Cancer Behavioral: Telerehabilitation group Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 72 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Investigator)
Primary Purpose: Treatment
Official Title: E-Cuidate: Effectiveness of a Telerehabilitation System in Women Breast Cancer Survivors
Study Start Date : March 2012
Actual Primary Completion Date : February 2014
Actual Study Completion Date : July 2014

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Experimental: Telerehabilitation group Behavioral: Telerehabilitation group
Interventions will be based on to provide cardiovascular, mobility, strength and stretching exercises through telerehabilitation system

No Intervention: Control group
Information about usual care

Primary Outcome Measures :
  1. Quality of life [ Time Frame: Participants will be followed over 8 weeks ]
    The primary outcome will be assessed with The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30) version 3.0. This questionnaire includes both multi-item scales and single-item measures. These are composed by five functional scales, three symptom scales, a global health status/QoL scale, and six single items. The scores have to be averaged and transformed linearly to obtain a range of score from 0 to 100 where high score meaning a great response level. The European Organization for Research and Treatment of Cancer Breast Cancer-Specific Quality of Life Questionnaire (EORTC QLQ-BR23) which is a breast cancer module of EORTC QLQ-C30 will also be assessed

Secondary Outcome Measures :
  1. Algometry [ Time Frame: Participants will be followed over 8 weeks ]
    The pressure pain thresholds (PPTs) will be measured through an electronic algometer (Somedic AB, Farsta, Sweden). PPTs over the C5-C6 zygapophyseal joint, deltoid muscle and tibialis anterior muscle will be assessed bilaterally. The mean of 3 trials will be used for the main analysis

  2. The Visual Analogue Scale (VAS) for pain [ Time Frame: Participants will be followed over 8 weeks ]
    This is a scale for subjective pain estimation that consists of line with a range scored of 0-10 where 0 means 'no pain' and 10 means 'worst pain imaginable'. Participants will have to mark of level of pain that they feel in that moment for both upper limb

  3. Pain [ Time Frame: Participants will be followed over 8 weeks ]
    The Brief Pain Inventory (BPI) short form will be used to assess pain severity and pain interference

  4. Body composition [ Time Frame: Participants will be followed over 8 weeks ]
    Height will be measured. Weight, body mass index, skeletal muscle mass and percentage of body fat will be obtained with bioelectrical impedance analysis (InBody 720; Biospace, Seoul, South Korea)

  5. Physical measurement [ Time Frame: Participants will be followed over 8 weeks ]
    • The Abdominal test (McQuade)
    • Measurement of upper body muscular strength: Handgrip strength will be determined using digital dynamometer (TKK 5101 Grip-D; Takey, Tokyo, Japan)
    • Measurement of back muscle strength: Back muscle strength will be assessed with digital dynamometer (TKK 5002 Back-A; Takey, Tokyo, Japan)
    • Lower body endurance: Multiple sit-to-stand test will be used to assess general lower extremity endurance

  6. Cardiorespiratory fitness [ Time Frame: Participants will be followed over 8 weeks ]
    • The International Fitness Scale (IFIS) will be used to evaluate perceived patients' overall fitness, cardio-respiratory fitness, muscular fitness, speed-agility and flexibility
    • Functional capacity: The 6-minute walk test using a treadmill (H-P-COSMOS for graphics; Germany) will be used to determine the maximum distance (meters) that can be walked in 6 min

  7. Fatigue [ Time Frame: Participants will be followed over 8 weeks ]
    The Piper Fatigue Scale-revised (R-PFS) includes 22 items and four dimensions such as behavioral/severity, affective meaning, sensory and cognitive/mood

  8. Anxiety and depression [ Time Frame: Participants will be followed over 8 weeks ]
    The Hospital Anxiety and Depression Scale (HADS) will be used to assess levels of anxiety and depression. It contains 14 items (7 items for each scale) with 4-point Likert scale

  9. Cognitive function [ Time Frame: Participants will be followed over 8 weeks ]
    • The Trail Making Test (TMT) will be used to assess speed for attention, sequencing, mental flexibility, visual search and motor function. The TMT consists of two parts (A and B)
    • The Auditory Consonant Trigram (ACT) will be used to test short-term memory, divided attention and information-processing capacity in adults

  10. Accelerometry [ Time Frame: Participants will be followed over 8 weeks ]
    Participants will be asked to wear an tri-axial accelerometer (ActiGraph GT3X+, Pensacola, Florida, US) for 8 consecutive days, starting the same day they receive the monitor, and will returned the accelerometers to the researcher 9 days later

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Diagnosis of stage I, II, or IIIA breast cancer
  • Medical clearance of participation
  • Without chronic disease or orthopaedic that would interfere with ability to participate in a physical activity program
  • Access to Internet
  • Basic ability to use the computer or living with a relative who has this ability
  • Completion of adjuvant therapy except for hormone therapy
  • No history of cancer recurrence
  • Have interest in improving lifestyle: fitness/stress level
  • Have signed informed consent

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01801527

Layout table for location information
Faculty of Health Sciences. University of Granada
Granada, Spain, 18071
Sponsors and Collaborators
Universidad de Granada
Carlos III Health Institute
Layout table for investigator information
Principal Investigator: Manuel Arroyo-Morales, PhD Faculty of Health Sciences. University of Granada
Additional Information:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Manuel Arroyo Morales, PhD, Universidad de Granada
ClinicalTrials.gov Identifier: NCT01801527    
Other Study ID Numbers: PI10/02749-02764
First Posted: February 28, 2013    Key Record Dates
Last Update Posted: October 27, 2017
Last Verified: October 2017
Keywords provided by Manuel Arroyo Morales, Universidad de Granada:
Breast cancer
Quality of life
Additional relevant MeSH terms:
Layout table for MeSH terms
Breast Neoplasms
Neoplasms by Site
Breast Diseases
Skin Diseases